"Thrombolytic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
| Descriptor ID |
D015912
|
| MeSH Number(s) |
E02.319.913
|
| Concept/Terms |
Thrombolytic Therapy- Thrombolytic Therapy
- Therapeutic Thrombolysis
- Therapeutic Thrombolyses
- Thrombolyses, Therapeutic
- Thrombolysis, Therapeutic
- Therapy, Fibrinolytic
- Fibrinolytic Therapies
- Therapies, Fibrinolytic
- Therapy, Thrombolytic
- Therapies, Thrombolytic
- Thrombolytic Therapies
- Fibrinolytic Therapy
|
Below are MeSH descriptors whose meaning is more general than "Thrombolytic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Thrombolytic Therapy".
This graph shows the total number of publications written about "Thrombolytic Therapy" by people in this website by year, and whether "Thrombolytic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 0 | 4 |
| 1996 | 1 | 2 | 3 |
| 1997 | 2 | 4 | 6 |
| 1998 | 3 | 1 | 4 |
| 1999 | 2 | 1 | 3 |
| 2000 | 6 | 5 | 11 |
| 2001 | 8 | 3 | 11 |
| 2002 | 1 | 1 | 2 |
| 2003 | 3 | 1 | 4 |
| 2004 | 7 | 3 | 10 |
| 2005 | 4 | 2 | 6 |
| 2006 | 3 | 0 | 3 |
| 2007 | 7 | 0 | 7 |
| 2008 | 3 | 2 | 5 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 2 | 4 |
| 2011 | 3 | 3 | 6 |
| 2012 | 1 | 0 | 1 |
| 2013 | 7 | 1 | 8 |
| 2014 | 2 | 1 | 3 |
| 2015 | 5 | 3 | 8 |
| 2016 | 4 | 0 | 4 |
| 2017 | 2 | 1 | 3 |
| 2018 | 3 | 2 | 5 |
| 2019 | 8 | 2 | 10 |
| 2020 | 7 | 4 | 11 |
| 2021 | 5 | 1 | 6 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 1 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombolytic Therapy" by people in Profiles.
-
Anti-stroke biologics: from recombinant proteins to stem cells and organoids. Stroke Vasc Neurol. 2024 Nov 05; 9(5):467-480.
-
Management of neonatal and infant aortic thrombosis: A single-center case series. Pediatr Blood Cancer. 2024 Nov; 71(11):e31283.
-
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Ann Neurol. 2024 Feb; 95(2):347-361.
-
Treatment of high- and intermediate-high-risk pulmonary embolism by the Pulmonary Embolism Response Team: Focus on catheter-directed therapies. Cardiol J. 2024; 31(2):215-225.
-
The association between cancer diagnosis, care, and outcomes in 1 million patients hospitalized for acute pulmonary embolism. Int J Cardiol. 2023 Jan 15; 371:354-362.
-
COVID-19 and Blood Clots: A Report of Massive Pulmonary Embolism in COVID-19 Patient Supported on Veno-Venous ECMO and the Utility of Thrombolysis. J Extra Corpor Technol. 2022 Sep; 54(3):235-238.
-
Diagnosis and Management of Pulmonary Embolism. Emerg Med Clin North Am. 2022 Aug; 40(3):565-581.
-
Thrombolysis Experience in Costa Rica Compared Against Individual Patient Data from two Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2022 Aug; 31(8):106599.
-
Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion. Pediatr Radiol. 2022 11; 52(12):2413-2420.
-
Impact of Telestroke Implementation on Emergency Department Transfer Rate. Neurology. 2022 04 19; 98(16):e1617-e1625.